AHCYL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.765400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.319200E-01
Normal-vs-Stage2
2.650800E-01
Normal-vs-Stage3
7.804800E-01
Normal-vs-Stage4
1.205190E-01
Stage1-vs-Stage2
1.800830E-01
Stage1-vs-Stage3
2.071000E-01
Stage1-vs-Stage4
5.591200E-01
Stage2-vs-Stage3
2.753600E-01
Stage2-vs-Stage4
8.919200E-01
Stage3-vs-Stage4
1.744790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.045000E-01
Normal-vs-AfricanAmerican
2.511200E-01
Normal-vs-Asian
2.236200E-01
Caucasian-vs-AfricanAmerican
2.409200E-01
Caucasian-vs-Asian
3.307600E-01
AfricanAmerican-vs-Asian
7.732800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.894200E-01
Normal-vs-Female
2.792000E-01
Male-vs-Female
8.609200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.219000E-01
Normal-vs-Age(41-60Yrs)
2.724200E-01
Normal-vs-Age(61-80Yrs)
2.812200E-01
Normal-vs-Age(81-100Yrs)
3.731000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.109000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.399200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.005000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.459800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.817000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.828200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.059800E-01
Normal-vs-Daily Drinker
3.057000E-01
Normal-vs-Weekly Drinker
1.407370E-01
Normal-vs-Occasional Drinker
2.178800E-01
Normal-vs-Social Drinker
1.630960E-01
Non Drinker-vs-Daily Drinker
8.533800E-01
Non Drinker-vs-Weekly Drinker
6.548800E-01
Non Drinker-vs-Occasional Drinker
8.977200E-01
Non Drinker-vs-Social Drinker
6.018000E-01
Daily Drinker-vs-Weekly Drinker
5.946800E-01
Daily Drinker-vs-Occasional Drinker
7.580600E-01
Daily Drinker-vs-Social Drinker
7.834800E-01
Weekly Drinker-vs-Occasional Drinker
7.045000E-01
Weekly Drinker-vs-Social Drinker
5.011400E-01
Occasional Drinker-vs-Social Drinker
5.384400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.310830E-01
Normal-vs-Grade 2
6.620200E-02
Normal-vs-Grade 3
1.867240E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.623810E-01
Grade 1-vs-Grade 3
5.504800E-01
Grade 1-vs-Grade 4
1.310830E-01
Grade 2-vs-Grade 3
5.031400E-01
Grade 2-vs-Grade 4
6.620200E-02
Grade 3-vs-Grade 4
1.867240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.026200E-01
Normal-vs-NonDiabetic
2.403200E-01
Diabetic-vs-NonDiabetic
7.692400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.334600E-01
Normal-vs-NoPancreatitis
2.983000E-01
Pancreatitis-vs-NoPancreatitis
4.453000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.649600E-01
Normal-vs-N1
2.786400E-01
N0-vs-N1
4.918400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.599820E-01
Normal-vs-TP53-NonMutant
2.643800E-04
TP53-Mutant-vs-TP53-NonMutant
7.043700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
